Man Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,769
| Closed | -$156K | – | 2270 |
|
|
2022
Q4 | $156K | Buy |
+26,769
| New | +$156K | ﹤0.01% | 1814 |
|
|
2021
Q2 | – | Sell |
-22,225
| Closed | -$111K | – | 2058 |
|
|
2021
Q1 | $111K | Sell |
22,225
-47,789
| -68% | -$239K | ﹤0.01% | 1793 |
|
|
2020
Q4 | $885K | Sell |
70,014
-2,100
| -3% | -$26.5K | ﹤0.01% | 1440 |
|
|
2020
Q3 | $708K | Sell |
72,114
-800
| -1% | -$7.85K | ﹤0.01% | 1458 |
|
|
2020
Q2 | $725K | Sell |
72,914
-11,587
| -14% | -$115K | ﹤0.01% | 1358 |
|
|
2020
Q1 | $747K | Sell |
84,501
-3,113
| -4% | -$27.5K | ﹤0.01% | 1181 |
|
|
2019
Q4 | $808K | Sell |
87,614
-500
| -0.6% | -$4.61K | ﹤0.01% | 1523 |
|
|
2019
Q3 | $518K | Sell |
88,114
-73,020
| -45% | -$429K | ﹤0.01% | 1560 |
|
|
2019
Q2 | $1.93M | Sell |
161,134
-3,700
| -2% | -$44.4K | 0.01% | 1308 |
|
|
2019
Q1 | $1.99M | Sell |
164,834
-1,691
| -1% | -$20.4K | 0.01% | 1327 |
|
|
2018
Q4 | $2.09M | Sell |
166,525
-138,230
| -45% | -$1.73M | 0.01% | 1194 |
|
|
2018
Q3 | $4.52M | Sell |
304,755
-21,800
| -7% | -$324K | 0.02% | 1041 |
|
|
2018
Q2 | $5.5M | Sell |
326,555
-19,070
| -6% | -$321K | 0.02% | 880 |
|
|
2018
Q1 | $7.92M | Buy |
+345,625
| New | +$7.92M | 0.04% | 587 |
|